Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Astrotech Corp. (NASDAQ: ASTC) Reports 512% Jump in YTD Revenue

  • Astrotech reported financial results for the quarter ended December 31, 2023, recording year-to-date revenue of $1,540,000
  • The company attributed the growth to the successful fulfillment of two significant purchase orders for the TRACER 1000(TM), the world’s first mass spectrometer-based explosive trace detectors (“ETD”), to customers in Romania
  • Astrotech is focused on commercializing its innovative platform mass spectrometry technology through its wholly owned subsidiaries 1st Detect Corp., AgLAB Inc., Pro-Control Inc., and BreathTech Corp.
  • The company and its subsidiaries are positioned to capitalize on burgeoning markets, including the global mass spectrometry market, expected to grow from an estimated $6.77 billion in 2024 to $9.17 billion by 2029

Astrotech (NASDAQ: ASTC), a science and technology development and commercialization company, focused on commercializing its innovative platform mass spectrometry technology through its wholly owned subsidiaries, recently released financial results for the three months ended December 31, 2023 (“Q2 2024”).

The company recorded a 512% jump in its year-to-date (“YTD”) revenue to $1,540,000 from $301,000 in the comparative period a year before. Astrotech attributed this growth primarily to two significant purchase orders for the TRACER 1000(TM) explosive trace detectors (“ETDs”) to customers in Romania, which the company, through 1st Detect Corp., successfully delivered on (https://cnw.fm/bDHtl).

The subsidiary 1st Detect develops, manufactures, and sells mass-spectrometer-based trace detectors – including the TRACER 1000(TM), the world’s first mass spectrometer-based ETD – for use in the security and detection markets. It is one of Astrotech’s wholly owned subsidiaries formed to explore and capitalize on opportunities in disparate markets. The other subsidiaries include Astrotech Technologies Inc, AgLAB Inc., Pro-Control Inc., and BreathTech Corp.

A recent SNS Insider article (https://cnw.fm/4ermr) confirms that “the Explosive Trace Detection Market is witnessing significant growth driven by increasing security concerns, particularly in transportation, critical infrastructure, and public spaces”.  Specifically, it indicates: “The Explosive Trace Detection Market, valued at USD 1137.50 million in 2022, is projected to achieve a significant milestone, reaching USD 2250.60 million by 2030.” This market is yet another fast-growing and important opportunity for 1st Detect and the superior mass spectrometry technology it offers. The article continues that “there is a growing demand for advanced ETD systems that offer higher sensitivity, faster detection times, and improved ease of use”, the very capabilities that 1st Detect represents. In particular, 1st Detect holds an exclusive AMS Technology license from ATI for air passenger and cargo security applications.

For its part, AgLAB has developed a mass-spectrometer-based chemical analyzer, the AgLAB 1000 series, and the AgLAB Maximum Value Process(TM) (“AgLAB MVP for use in botanical distillation and specifically, the hemp and cannabis sectors. AgLAB uses its proprietary mass spectrometry instrumentation on the manufacturing floor to test and analyze distilled cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”) oils quickly, easily, and continually, providing immediate information that not only maximizes potency but also improves the ending weight yields of every batch. According to AgLAB’s analysis, its mass spectrometers improve yields by an average of 34% (https://cnw.fm/2bp9w).

The U.S. cannabis market, which combines the recreational cannabis, medical cannabis, and therapeutic cannabis segments, is expected to experience significant growth in the coming years, according to Statista, reaching a projected $39.85 billion in revenue in 2024 and $67.15 billion by the end of 2028. The market is projected to grow at a CAGR of 13.93% during this forecast period (https://cnw.fm/SApA8). Globally, the cannabis market is projected to reach revenue of $60.79 billion in 2024 and $102.90 billion by 2028, representing a CAGR of 14.06% (https://cnw.fm/AksQn).

Beyond the U.S. cannabis and cannabinoids markets, Astrotech is positioned to capitalize on and benefit from the growth in the global mass spectrometry market, which is expected to grow from an estimated $6.77 billion in 2024 to $9.17 billion by 2029, representing a CAGR of 6.25%. “One of the major driving factors for the growth of the mass spectrometry market is the technological advancements in mass spectrometer devices,” wrote Mordor Intelligence in its report (https://cnw.fm/ZARLT).

Pro-Control subsidiary is expected to benefit from the global industrial automation and control systems market that is valued at USD 172.26 billion in 2022 with a compound annual growth rate (“CAGR”) of 10.5% from 2023 to 2030. The Pro-Control 1000(TM) mass spectrometer is designed to measure, test, and increase efficiencies in the chemical manufacturing processes.

Pro-Control MVP(TM) uses mass spectrometry instrumentation to monitor and control the fractional distillation of bulk chemicals using real-time in-process samples. “The Pro-Control subsidiary was launched late Q2 2024, and we look forward to introducing Pro-Control to chemical manufacturers who are using all types of distillation,” said Thomas B. Pickens, III, Astrotech’s Chairman, CEO, and CTO.

The BreathTech subsidiary is continuing its development of a breath analysis device that can provide early detection of lung diseases so that targeted antibiotics can be administered within minutes vs. days under current lab conditions. “The early BreathTech work was focused on COVID, but as vaccines were introduced and the effect of the disease outbreaks diminished, we have expanded our breath work to include other lung diseases that would benefit from early identification,” said Mr. Pickens.

The BreathTech subsidiary is continuing its development of a breath analysis device that can to provide early detection of lung diseases so that targeted antibiotics can be administered within seconds vs. days under current lab conditions. “The early BreathTest work was directed exclusively to COVID, but as the vaccines too effect and the disease outbreaks diminished, we have expanded our breath work to include other lung diseases that would benefit from early identification. The testing of these diseases is ongoing and we remain optimistic over our most recent results,” said Mr. Pickens.

For more information, visit the company’s website at www.AstrotechCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to ASTC are available in the company’s newsroom at https://cnw.fm/ASTC

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Closing of $3.6 Million Registered Direct Offering

  • Lexaria, a global innovator in drug delivery platforms, just announced $3.6 million in gross proceeds from its registered direct offering priced at the market
  • The proceeds will go to critical R&D studies, patent, and legal costs, as well as general working capital purposes
  • This is timely, given Lexaria’s resolve to double down on GLP-1 investigations for the 2024 calendar year

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced that the registered direct offering for the purchase and sale of 1,558,443 shares of common stock at a purchase price of $2.31 – at the market under Nasdaq rules – per share yielded approximately $3.6 million in gross proceeds. This was offered by the company pursuant to a “shelf” registration statement on Form S-3 (File No. 333-262402), and it opens Lexaria to important new opportunities for the 2024 calendar year (https://cnw.fm/9CHup).

Most notably, Lexaria intends to use the net proceeds from this offering for research and development (“R&D”) studies, and the associated patent and legal costs. It also intends to use the funds for general working capital purposes, important for its current focus on GLP-1 clinical studies for the 2024 calendar year.

“Our R&D plans for 2024 are very tightly focused and will be concentrated mainly on GLP-1 investigations,” noted Chris Bunka, Lexaria’s CEO (https://cnw.fm/RIBhV).

In 2023, Lexaria laid down the groundwork for its GLP-1 clinical studies. The company achieved positive interim and final human pilot study results using a single semaglutide dose of a Rybelsus(R) tablet to a matching dose of Rybelsus that had been processed with DehydraTECH (TM) processing technology enhancements.

“Frankly, the results surprised us with their level of positivity,” noted Mr. Bunka.

“It was found that DehydraTECH processing: delivered a statistically-significant higher proportion of the semaglutide, and did so more quickly (very typical of results for our technology); reduced the quantity and severity of unwanted side effects; and had a statistically-significant impact on blood sugar in general and much more effectively after eating a meal, than did Rybelsus,” he added.

These results inspired the confidence of Lexaria’s team. In addition, the FDA’s recognition of GLP-1 drugs, having offered approvals as recently as 2021 and 2022 due to its health benefits, incentivized Lexaria to double down on this specific study. Consequently, the $3.6 million could not have come at a better time. Mr. Bunka and the rest of Lexaria’s management are optimistic that with this focus, the team’s hard work will prove its worth this year.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW – Legal Opinion Asserts That Rescheduling Cannabis Won’t Violate US International Obligations

A recent legal opinion has challenged the U.S. Drug Enforcement Administration’s (“DEA”) stance, suggesting that international treaties related to drugs should not hinder cannabis rescheduling as recommended by the U.S. Department of Health and Human Services (“HHS”). According to the opinion, doing so would be more in line with the country’s duties under international legislation to regulate marijuana in a manner that safeguards public safety and health.

Prepared by lawyers from Vicente LLP and Porter Wright LLP firms, the opinion aims to counter the DEA’s assertion in 2016, when it denied a previous request for a cannabis rescheduling. At the time, the agency maintained that cannabis could not be classified under a less stringent schedule than Schedule II because of international drug agreements.

The legal paper contends, however, that these treaties give countries enough latitude to create drug laws that put national welfare and health first, even if doing so means ending prohibition.

The Coalition for Cannabis Scheduling Reform, an advocacy group and association representing various marijuana-related groups and businesses, commissioned the paper, which has been shared among members and in private with key government figures.

While concerns have previously been raised by individuals such as Representative Andy Harris regarding treaty obligations, noting potential violations of the Single Convention of 1961, a group of senators has highlighted revisions to global marijuana scheduling laws, citing countries such as Canada, which have legalized and regulated cannabis without repercussions. The writers point to Canada and Uruguay in support of their reading that international drug treaties broadly support regulating drugs for safety, research and medical applications. Further, they note that the DEA has in the past rescheduled a cannabis-based medication, Epidiolex, after it received FDA approval, showing that there has been precedent for changing the categorization of cannabis.

The opinion not only refutes the notion that drug treaties forbid cannabis reclassification, but it also emphasizes the member nations’ latitude in upholding treaties even when doing so contradicts their internal constitutions.

This becomes especially important in the case of the adult-use cannabis markets that are already operating and have been approved by state legislation. The opinion argues that closing state markets on treaty grounds would violate states’ fundamental constitutional rights and highlights the existence of treaty exceptions when constitutional constraints are in effect. Moreover, the opinion underscores the legal discrepancy between the final rule and final order in DEA rescheduling proceedings, suggesting that treaty obligations could enable the agency to bypass the rulemaking process.

The legal opinion above could help shape the final decision that the DEA makes, although industry actors such as Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) are only awaiting a communication from the federal agency so that they can assess how their strategic plans could evolve based on the changed regulatory climate in the United States.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

First Marijuana Consumption Lounge in Nevada Set to Open by Month’s End

Earlier this month, the Nevada Cannabis Control Board announced that it had awarded its first marijuana consumption lounge license. This announcement comes after the board approved a handful of these licenses over the last couple months.

The first to receive a lounge license was Thrive Cannabis Marketplace. Mitch Britten, CEO and managing partner of Thrive, stated that the company was honored to be at the forefront of the marijuana industry in Nevada through the official launch of the first regulated marijuana lounge in the state.

Britten revealed that the company had created a unique destination for marijuana enthusiasts to enjoy an assorted range of premium products in an engaging atmosphere. The lounge, dubbed Smoke and Mirrors, will provide a curated selection of premium marijuana products, including infused beverages.

It is important to keep in mind that alcohol will not be offered on the premises in accordance with state law. The compliance board also issued a statement about the company, noting that it was the first lounge that was inspected by its agents and adhered to the stipulated regulations.

A conditional license was issued to Thrive in June of last year. The zoning commission from Clark County then issued the company a special use permit in September. The lounge was then inspected in February of this year, which enabled Thrive to obtain its operation license.

In addition, the Nevada Cannabis Control Board revealed that 19 lounges had received approval for conditional licenses thus far. Of this number, five are independently situated and 14 are attached to dispensaries. The first independently located consumption lounge to receive a license was LA Lounge LLC.

Thrive’s lounge will operate in what was once a strip club and may be launched by the end of February, if all goes well.

Tyler Klimas, former executive director of the cannabis control board, recently discussed marijuana consumption lounges on a Weed Wonks podcast. He talked about how this was an unknown space and noted that many businesses would be launched in the near future.

The other consumption lounge that received a conditional license, Planet 13, issued a statement on a possible date for its launch. Larry Scheffler, Planet 13 co-CEO, stated that the company’s objective was to create an extraordinary space for marijuana connoisseurs, novices, locals and tourists to enjoy marijuana while experiencing world-class entertainment. The Planet 13 lounge will have bong chandeliers, VIP booths and marijuana cocktails.

The third conditional license was granted to SoL Cannabis.

The launch of these consumption lounges is likely to be watched closely by cannabis companies such as TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) since their success is likely to be copied in other jurisdictions where legal sales of adult-use marijuana exist.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW – Medical Cannabis Could Be Legalized in Spain, But Not Everyone Is Thrilled

Spain is making strides toward legalizing marijuana for medical use, with the Health Ministry initiating the introduction of new legislation to sanction its therapeutic application across various conditions. Reports from the Spanish media indicate that the proposed law is currently undergoing a phase of consultation and discussion. Residents, professionals and experts are asked to contact the ministry via email during this period to express their views on the subject.

Recently, Spain health secretary Javier Padilla had talks with scientific societies and professional associations after holding conversations with the EU Observatory of Marijuana Consumption and Cultivation. Further consultations are planned with the Spanish OECM.

The ministry noted that the upcoming bill is a well-thought-out policy based on recent scientific findings. Additionally, it said that the effectiveness of marijuana as a therapy alternative will be regularly assessed, with an emphasis on patient safety and product quality.

The regulatory framework aims to remain adaptable, rapidly integrating new evidence on marijuana’s medical benefits as it emerges.

However, there are dissenting voices, particularly regarding the exclusion of cannabis buds and home cultivation, which many patients advocate for. Initial provisions suggest that authorized medical cannabis products will primarily comprise oils, prescribed solely by SNS-approved doctors rather than private entities. Furthermore, only hospital pharmacists will be able to dispense the medications, which will restrict accessibility in comparison to the widely available corner dispensaries.

Currently, eligible patients include those undergoing chemotherapy for managing symptoms such as refractory pain, seizures, vomiting and nausea. The list of qualifying conditions is expected to expand in the future, according to sources.

Spain’s move toward medical marijuana legalization aligns with similar efforts in other European nations, including Portugal and Norway. The decision also reflects the growing demand for medical marijuana, with Spain projecting a significant increase in production to meet patient needs.

The Health Ministry anticipates producing 36 tons of medical marijuana this year, which is a 12.5-ton increase from last year. The increase is in line with a significant upward trend in medical marijuana output in the nation that began in 2022.

Approximately 400 kilograms were produced in 2018, according to the AEMPS, with an estimated 600 kilograms produced in 2021. This amount, however, increased dramatically to six tons in 2022 and then further quadrupled to 24 tons in 2023. More than 80% of this amount was exported for use as medical marijuana, with less than 20% reserved for research.

The numbers indicate that Spain has surpassed Portugal, which is frequently regarded as the center of Europe’s medical marijuana export industry and is predicted to generate 32 tons this year.

The growing wave of cannabis law reform around the world could open many international markets for established cannabis companies such as Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) that have gained immense experience in the North American market where they currently operate.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW – Prohibitionist States See Nearly Double Search Traffic for Delta-8 THC as Legal States

A recent study on the online search behavior concerning delta-8 THC says that the cannabinoid seems to be substantially more common in states where cannabis is still prohibited, based on information obtained from Google Trends. According to an analysis by CBD Nationwide, delta-8 THC online searches were almost twice as common in states where recreational marijuana is still illegal. This indicates that there has been a notable movement toward other cannabinoids in reaction to marijuana prohibitions.

A contributing factor to the popularity of delta-8 in these states is its extensive availability, both online and in physical stores such as gas stations, smoke shops and convenience stores. The cannabinoid, which is usually derived from hemp or synthesized from different parts of the plant, is legal in the United States.

According to the company, the difference in interest in the substance between states with differing cannabis laws was statistically significant, and the results were unlikely to have been caused by random chance, as evidenced by the very low p-value.

Google searches for the cannabinoid have increased dramatically in recent years, the study noted, with an 850% spike in the year 2021 alone. According to a 2023 AMA study, states that prohibit cannabis use may unintentionally promote the use of delta-8 items, a trend likely aggravated by hemp being federally legalized under the Farm Bill 2018.

The CBD Nationwide study indicated that there is more interest in delta-9 THC in states where cannabis is illegal, albeit to a lesser extent. To validate the results, the analysis used statistical tests such as Tukey’s Honestly Significant Difference (HSD) tests and analysis of variance (ANOVA).

The study, however, did not delve into the specific context of these searches, leaving it unclear if individuals in states where cannabis is illegal were seeking cannabinoid products or simply researching related laws and scientific information. Legislators, activists and business interests all have different opinions about how to regulate newly discovered cannabinoids. Certain states have chosen to prohibit or limit the sale of the substances, while others support updated federal regulations that treat intoxication cannabinoids apart from CBD.

State cannabis authorities have asked Congress to take into account laws that cover a wider range of newly discovered cannabinoids rather than only CBD.

Congress is expected to discuss the issue during the upcoming Farm Bill negotiations, which have been delayed due to a short-term extension of the existing legislation.

The analysis of search traffic shows that ending prohibition and letting cannabis companies such as Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED) to operate within a regulated marketplace facilitates public health because residents will not be pushed to try alternatives sourced from gray- or black-market actors.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks — Marigold PR Announces Upcoming Radicle Femmes Event Focused on Women in Cannabis

Marigold PR, an award-winning public relations agency to the North American cannabis industry, announced that it is hosting the first-ever Radicle Femmes event. According to the announcement, Radicle Femmes is designed to be Canada’s largest networking event celebrating women in cannabis. The premiere event is slated for March 8, 2024, which is International Women’s Day; it will be held in Toronto in collaboration with several sponsors, including the Ontario Cannabis Store, the Panther Group, Sister Merci and Solei. The event is designed to highlight the achievements of women entrepreneurs, professionals and advocates in shaping the industry landscape. The agenda includes panel discussions and networking events that focus on topics ranging from challenges that women to face to access to funding and low representation in the space. The one-day event will include entrepreneurs, marketers, consultants, retail decision-makers, licensed producers, brand representatives and other ancillary services.

“Women are underrepresented in leadership positions in many industries, including the cannabis industry, despite their significant contribution to the sector,” said Ontario Cannabis Store vice president of corporate affairs, social responsibility and strategic engagement Tanya Watkins in the press release. “The OCS’s commitment to enabling a vibrant cannabis marketplace is tied to supporting a diverse and inclusive industry. We’re proud to sponsor Radicle Femmes, which celebrates the many contributions of women who continue pushing the legal cannabis industry forward.”

To view the full press release, visit https://cnw.fm/dEYjr

About Marigold PR

Marigold PR has become a leading force in elevating the profile of the cannabis industry through strategic communications and high-impact events. As an award-winning public relations agency, Marigold PR has established a portfolio that includes a diverse range of clients, from emerging startups to established industry leaders. Marigold PR has been instrumental in supporting and hosting high-profile cannabis events and conferences that serve as a nexus for like-minded businesses, thought leaders and influencers in the cannabis space. For more information about the company, visit www.MarigoldPR.com.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – MAISON BLOOM Announces New Owner-Partner as UFC Fighter, Entrepreneur Joins Company

MAISON BLOOM, creators of the world’s first all-natural elevated seltzer made from fully sustainable ingredients, has announced a new owner-partner. Marlon “Chito’ Vera, a well-known UFC fighter and entrepreneur, has joined the company, taking “a leap into the world of infused beverages and functional cannabinoid ready-to-drink beverages” as part of his mission to share his approach to “always-ready-living” with the world. Vera will serve as the company’s head of wellness. With Vera on board, MAISON BLOOM plans to launch the “Chito Challenge,” which will include a series of bold offerings and engagements that encourage people to live their best lives. According to the announcement, Vera lives by the mantra of “always being in fighting shape,” and he will be bringing that mentality to MAISON BLOOM, intent on changing the perception of infused beverages and joining the best in the craft-infused beverage category. “Chito is the epitome of an intentional purpose-driven athlete, and as soon as we got to talking, it was clear that he shares the same energy, drive and vision to sip into a life less ordinary,” said MAISON BLOOM CEO Nathan Johnson in the press release. “He’s got that B.C.E – Big Champion Energy – and we are so excited to bring his drive, energy and enthusiasm to the world of MAISON BLOOM’s infused beverages because it really is high time to drink different, eat cleaner, and live better.”

To view the full press release, visit https://cnw.fm/vwvpj

About MAISON BLOOM

MAISON BLOOM stands as the pioneer in the world’s first designer, full-spectrum, hemp-infused family of beverages. Emerging in 2020 during lockdown, MAISON BLOOM is dedicated to the clean food and beverage movement and stacking up awards year after year thanks to the company’s commitment to delivering premium infused Malternative(TM) Elevated Seltzers that offer a distinctive full-spectrum experience. MAISON BLOOM delivers on the promise of the freshness of homemade creations with fewer calories and low and natural sugars; MAISON BLOOM beverages are GMO free and additive free and are always ready to drink, thanks to the use of 100% pure, plant-based ingredients. For more information, visit the company website at www.LiveMaisonBloom.com.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW – Experts Say Marijuana Potency Has Dramatically Increased Over the Years

There has been a significant growth in both the THC potency and range of cannabis products in recent decades, according to recent research by the University of Mississippi’s School of Pharmacy. The study, conducted through the university’s Natural Center for Natural Products Research, involved testing marijuana samples seized in federal raids during the last 50 years. The findings reveal a significant increase in potency, with modern cannabis flower being 57%–67% stronger compared to those from the 1970s.

Since legalization in most states, such as Michigan, the cannabis market has undergone strict regulation and has expanded to provide users with even more potent products. Tyler Dutcher, who owns Barryton-based grow facility Vivid Farms, acknowledges the availability of highly potent products but also emphasizes the presence of lower dosage varieties to cater to different preferences.

Dutcher advises beginning with goods such as flower strains or infused edibles that have about 20% potency and progressively modifying the dosage according to personal tolerance. He notes that taking these products will give users greater control over their dosage.

Recent studies have investigated the link between cannabis use and psychosis, with The New York Times reporting on the risks associated with regular marijuana use, especially among teenagers and young adults. Another study published in the Missouri State Medical Association Journal in 2018 revealed that high-potency THC (greater than 15%) increased the psychosis risk threefold, with daily use leading to a fivefold increase in risk among individuals under the age of 18 years.

Timber Cannabis marketing representative Chivonne Rush notes that regulated dispensaries prioritize only adult cannabis use and are committed to educating consumers about the potential risks associated with marijuana use, particularly among youth. According to the Addiction Center, higher THC levels in marijuana products increase the likelihood of addiction and dependence. The organization noted that it is critical to find and carry out efficient treatment programs for people struggling with addiction disorders and that it is also critical to raise youth awareness of the risks and hazards that come with using these substances.

Dutcher advocates starting with smaller doses and being watchful for any unpleasant effects when it comes to intake, especially for nonregular users. He reassures that although some people may experience discomfort from consuming strong cannabis, major injury is unlikely and that education from trained staff at cannabis dispensaries is essential to encouraging appropriate consumption habits.

Given that marijuana industry actors have to compete with black-market products, the subject of the rising potency of cannabis products is more nuanced than one may initially think.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – Software Effective Solutions Corp. (SFWJ) to Expand Portfolio with Strategic Acquisition

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana), a leading holding company in the cannabis industry, today announced final stages of negotiations to acquire its sixth cannabis company in Colombia. The acquisition is extremely significant because of the company’s cannabis genetics license, which MedCana believes will revolutionize its potential to create and register unique cannabis genetic varieties for production and commercialization. “The addition of this new company to MedCana’s portfolio represents a significant leap forward in our commitment to innovation and excellence within the cannabis sector,” said Gabriel Diaz, CEO of MedCana. “By integrating this company’s cutting-edge genetics capabilities, MedCana will be poised to develop proprietary cannabis strains, enhancing the diversity and quality of our product offerings to meet the evolving needs of consumers and medical patients alike.”

To view the full press release, visit https://cnw.fm/NKN1E

About Software Effective Solutions Corp.

Software Effective Solutions/MedCana is a holding company focused on developing companies in the agricultural technology and cannabis industries. As MedCana moves forward with its expansion plans, the company remains committed to delivering on its promise of building a solid foundation for the future growth of its holdings. For more information, visit the company’s website at www.MedCana.net.

NOTE TO INVESTORS: The latest news and updates relating to SFWJ are available in the company’s newsroom at https://cnw.fm/SFWJ

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN